Estimates Revisions Maravai LifeSciences Holdings, Inc.
Stocks
MRVI
US56600D1072
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
00:00:00 03/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 7.900 USD | +5.33% |
|
+3.95% | +143.08% |
| 09-30 | Maravai's TriLink Gets New China Patent for CleanCap Technology | MT |
| 09-09 | UBS Adjusts Maravai Lifesciences Price Target to $8 From $2.50, Maintains Neutral Rating | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- MRVI Stock
- Consensus Maravai LifeSciences Holdings, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
